TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Italy Fines Apple €98.6 Million Over App Store Dominance 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
The Apple Watch Series 7 could be a vital gadget for smartwatch users with diabetes. The upcoming wearable device is reportedly launching with a new medical monitoring feature later this year.
Apple Watch Series 7 is reportedly launching with a new sensor
The latest Apple Watch models are some of the most advanced of its kind, especially when it comes to sensors that help users monitor different aspects of their health. The support for the ECG app and tracking blood oxygen levels are some of the health-related features offered by Apple’s latest smartwatches.
If the ET News report was accurate, the Apple Watch Series 7 could become even more useful, especially for smartwatch users dealing with diabetes. Apple and Samsung are purportedly planning to introduce a new feature that would utilize optical sensors to monitor the user’s blood sugar level without blood sampling.
The Apple Watch Series 7, as well as the Samsung Galaxy Watch 4, are both rumored to feature an optical sensor making the non-invasive blood glucose level monitoring possible. As for Apple’s upcoming device, it is worth noting that the company previously had a patent granted that could be related to this technology.
The patent titled “Reference switch architectures for noncontact sensing of substances” was filed in 2016 and was granted to Apple last October. It is described as relating to “systems and methods for measuring a concentration and type of substance in a sample at a sampling interface.”
It should be a massive help to diabetics if the Apple Watch Series 7 or the Samsung Galaxy Watch 4 would actually launch with a non-invasive blood glucose level monitoring system. According to Mayo Clinic, people with type 1 diabetes could be recommended by their physicians to check their blood sugar levels four to 10 times every day.
Apple Watch Series 7 release date likely in fall 2021
It is worth noting that Apple does not hesitate to delay an important feature due to its high standards for its new hardware products. So even if it is true that a blood sugar level monitoring system is in the works, its launch through the Apple Watch Series 7 is not guaranteed until Apple officially makes the announcement.
Apple fans will have to wait until fall to see if this report becomes a reality. Since 2016, a new generation of Apple Watch has been unveiled in September every year. The tech giant is likely to maintain that release window for the Apple Watch Series 7 this year.
